Literature DB >> 27229123

Colonic macrophage polarization in homeostasis, inflammation, and cancer.

Raymond A Isidro1, Caroline B Appleyard2.   

Abstract

Our review focuses on the colonic macrophage, a monocyte-derived, tissue-resident macrophage, and the role it plays in health and disease, specifically in inflammatory conditions such as inflammatory bowel disease and cancer of the colon and rectum. We give special emphasis to macrophage polarization, or phenotype, in these different states. We focus on macrophages because they are one of the most numerous leukocytes in the colon, and because they normally contribute to homeostasis through an anti-inflammatory phenotype. However, in conditions such as inflammatory bowel disease, proinflammatory macrophages are increased in the colon and have been linked to disease severity and progression. In colorectal cancer, tumor cells may employ anti-inflammatory macrophages to promote tumor growth and dissemination, whereas proinflammatory macrophages may antagonize tumor growth. Given the key roles that this cell type plays in homeostasis, inflammation, and cancer, the colonic macrophage is an intriguing therapeutic target. As such, potential macrophage-targeting strategies are discussed.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  colon; colorectal cancer; inflammatory bowel disease; macrophage polarization; macrophages

Mesh:

Substances:

Year:  2016        PMID: 27229123      PMCID: PMC4967174          DOI: 10.1152/ajpgi.00123.2016

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  105 in total

Review 1.  Alternative activation of macrophages: an immunologic functional perspective.

Authors:  Fernando O Martinez; Laura Helming; Siamon Gordon
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

2.  An independent subset of TLR expressing CCR2-dependent macrophages promotes colonic inflammation.

Authors:  Andrew M Platt; Calum C Bain; Yvonne Bordon; David P Sester; Allan McI Mowat
Journal:  J Immunol       Date:  2010-05-07       Impact factor: 5.422

3.  Distinctive histopathologic phenotype in resection specimens from patients with Crohn's disease receiving anti-TNF-α therapy.

Authors:  David F Schaeffer; Joanna C Walsh; Richard Kirsch; Matti Waterman; Mark S Silverberg; Robert H Riddell
Journal:  Hum Pathol       Date:  2014-06-12       Impact factor: 3.466

4.  Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials.

Authors:  Jun Shen; Zhi-Xiang Zuo; Ai-Ping Mao
Journal:  Inflamm Bowel Dis       Date:  2014-01       Impact factor: 5.325

5.  Human intestinal epithelial cells express interleukin-10 through Toll-like receptor 4-mediated epithelial-macrophage crosstalk.

Authors:  Jinhee Hyun; Laura Romero; Reldy Riveron; Claudia Flores; Saravana Kanagavelu; Kristina D Chung; Ana Alonso; John Sotolongo; Jose Ruiz; Armine Manukyan; Sally Chun; Gaurav Singh; Pedro Salas; Stephan R Targan; Masayuki Fukata
Journal:  J Innate Immun       Date:  2014-08-20       Impact factor: 7.349

6.  A single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice.

Authors:  Atsushi Hayashi; Toshiro Sato; Nobuhiko Kamada; Yohei Mikami; Katsuyoshi Matsuoka; Tadakazu Hisamatsu; Toshifumi Hibi; Axel Roers; Hideo Yagita; Toshiaki Ohteki; Akihiko Yoshimura; Takanori Kanai
Journal:  Cell Host Microbe       Date:  2013-06-12       Impact factor: 21.023

7.  Targeting colon cancer cell NF-κB promotes an anti-tumour M1-like macrophage phenotype and inhibits peritoneal metastasis.

Authors:  A E Ryan; A Colleran; A O'Gorman; L O'Flynn; J Pindjacova; P Lohan; G O'Malley; M Nosov; C Mureau; L J Egan
Journal:  Oncogene       Date:  2014-04-07       Impact factor: 9.867

8.  M-CSF instructs myeloid lineage fate in single haematopoietic stem cells.

Authors:  Noushine Mossadegh-Keller; Sandrine Sarrazin; Prashanth K Kandalla; Leon Espinosa; E Richard Stanley; Stephen L Nutt; Jordan Moore; Michael H Sieweke
Journal:  Nature       Date:  2013-04-10       Impact factor: 49.962

9.  MyD88 signalling in colonic mononuclear phagocytes drives colitis in IL-10-deficient mice.

Authors:  Namiko Hoshi; Dominik Schenten; Simone A Nish; Zenta Walther; Nicola Gagliani; Richard A Flavell; Boris Reizis; Zeli Shen; James G Fox; Akiko Iwasaki; Ruslan Medzhitov
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

10.  Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis.

Authors:  Josep Bassaganya-Riera; Monica Viladomiu; Mireia Pedragosa; Claudio De Simone; Adria Carbo; Rustem Shaykhutdinov; Christian Jobin; Janelle C Arthur; Benjamin A Corl; Hans Vogel; Martin Storr; Raquel Hontecillas
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.752

View more
  64 in total

Review 1.  ALOX15 as a suppressor of inflammation and cancer: Lost in the link.

Authors:  Rui Tian; Xiangsheng Zuo; Jonathan Jaoude; Fei Mao; Jennifer Colby; Imad Shureiqi
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-01-13       Impact factor: 3.072

Review 2.  Role of prostanoids in gastrointestinal cancer.

Authors:  Dingzhi Wang; Raymond N DuBois
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

3.  Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses.

Authors:  Kshipra Singh; Lori A Coburn; Mohammad Asim; Daniel P Barry; Margaret M Allaman; Chanjuan Shi; M Kay Washington; Paula B Luis; Claus Schneider; Alberto G Delgado; M Blanca Piazuelo; John L Cleveland; Alain P Gobert; Keith T Wilson
Journal:  Cancer Res       Date:  2018-05-31       Impact factor: 12.701

Review 4.  Progress on Modulating Tumor-Associated Macrophages with Biomaterials.

Authors:  Meilyn Sylvestre; Courtney A Crane; Suzie H Pun
Journal:  Adv Mater       Date:  2019-09-27       Impact factor: 30.849

Review 5.  Macrophage phenotype in response to ECM bioscaffolds.

Authors:  Luai Huleihel; Jenna L Dziki; Joseph G Bartolacci; Theresa Rausch; Michelle E Scarritt; Madeline C Cramer; Tatiana Vorobyov; Samuel T LoPresti; Ilea T Swineheart; Lisa J White; Bryan N Brown; Stephen F Badylak
Journal:  Semin Immunol       Date:  2017-07-21       Impact factor: 11.130

Review 6.  The mucosal immune system: master regulator of bidirectional gut-brain communications.

Authors:  Nick Powell; Marjorie M Walker; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-18       Impact factor: 46.802

7.  The Probiotic VSL#3 Modulates Colonic Macrophages, Inflammation, and Microflora in Acute Trinitrobenzene Sulfonic Acid Colitis.

Authors:  Raymond A Isidro; Abdon Lopez; Myrella L Cruz; Mayra I Gonzalez Torres; Gladys Chompre; Angel A Isidro; Caroline B Appleyard
Journal:  J Histochem Cytochem       Date:  2017-07-10       Impact factor: 2.479

8.  Reference gene selection and validation for mRNA expression analysis by RT-qPCR in murine M1- and M2-polarized macrophage.

Authors:  Wen Ju; Tiantian Sun; Wenyi Lu; Alhaji Osman Smith; Yurong Bao; Seyram Yao Adzraku; Kunming Qi; Kailin Xu; Jianlin Qiao; Lingyu Zeng
Journal:  Mol Biol Rep       Date:  2020-03-19       Impact factor: 2.316

Review 9.  Macrophage polarization and meta-inflammation.

Authors:  Chuan Li; Maria M Xu; Kepeng Wang; Adam J Adler; Anthony T Vella; Beiyan Zhou
Journal:  Transl Res       Date:  2017-11-03       Impact factor: 7.012

10.  NKp46+ lamina propria natural killer cells undergo metabolic reprogramming in a mouse experimental colitis model.

Authors:  Hongjian Zhou; Xingwang Xie; Bin Jiang; Chao Ke
Journal:  Inflamm Res       Date:  2020-02-10       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.